To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
20 U.S.C. 1067q 21 U.S.C. 321
and
355 42 U.S.C. 1320a-7b, 18116, 262
and
283
Document Citations
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. NIH Clinical Trial Integrity Act. H.R. 6867. 119th
Cong., 1st
sess., Introduced in House December 18, 2025. https://www.govinfo.gov/app/details/BILLS-119hr6867ih.
APA
Congress, House of Representatives (2025, December 18). NIH Clinical Trial Integrity Act (H.R. 6867 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr6867ih.
MLA
United States, Congress, House of Representatives. NIH Clinical Trial Integrity Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr6867ih. 119th Congress, H.R. 6867, Introduced in House 18 Dec. 2025.
